Pandey S, Bapat V, Abraham J, Abraham N
World J Otorhinolaryngol Head Neck Surg. 2024; 10(2):137-147.
PMID: 38855289
PMC: 11156689.
DOI: 10.1002/wjo2.175.
Williams G, Muskat K, Frazier A, Xu Y, Mateus J, Grifoni A
J Neurol Sci. 2022; 444:120510.
PMID: 36495691
PMC: 9950758.
DOI: 10.1016/j.jns.2022.120510.
Smeyne R, Eells J, Chatterjee D, Byrne M, Akula S, Sriramula S
Mov Disord. 2022; 37(7):1394-1404.
PMID: 35579496
PMC: 9347874.
DOI: 10.1002/mds.29116.
Hess D, Rutkowski E, Morgan J, McCluskey L
Cond Med. 2021; 3(5):241-245.
PMID: 34136764
PMC: 8205429.
Bhidayasiri R, Virameteekul S, Kim J, Pal P, Chung S
J Mov Disord. 2020; 13(2):105-114.
PMID: 32344993
PMC: 7280938.
DOI: 10.14802/jmd.20042.
Can infections trigger alpha-synucleinopathies?.
Tulisiak C, Mercado G, Peelaerts W, Brundin L, Brundin P
Prog Mol Biol Transl Sci. 2019; 168:299-322.
PMID: 31699323
PMC: 6857718.
DOI: 10.1016/bs.pmbts.2019.06.002.
Saskatchewan movement disorders program.
Rajput A, Rajput A
Can J Neurol Sci. 2015; 42(2):74-87.
PMID: 25804247
PMC: 4416358.
DOI: 10.1017/cjn.2015.13.
Neurologic aspects of influenza viruses.
Davis L, Koster F, Cawthon A
Handb Clin Neurol. 2014; 123:619-45.
PMID: 25015508
PMC: 7152431.
DOI: 10.1016/B978-0-444-53488-0.00030-4.
Biophysical Characterization of α-Synuclein and Rotenone Interaction.
Silva B, Einarsdottir O, Fink A, Uversky V
Biomolecules. 2014; 3(3):703-32.
PMID: 24970188
PMC: 4030960.
DOI: 10.3390/biom3030703.
The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease.
Estupinan D, Nathoo S, Okun M
Parkinsons Dis. 2013; 2013:167843.
PMID: 23853734
PMC: 3693163.
DOI: 10.1155/2013/167843.
Viruses and neurodegeneration.
Zhou L, Miranda-Saksena M, Saksena N
Virol J. 2013; 10:172.
PMID: 23724961
PMC: 3679988.
DOI: 10.1186/1743-422X-10-172.
Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.
Silva B, Breydo L, Uversky V
Mol Neurobiol. 2012; 47(2):446-59.
PMID: 22940885
DOI: 10.1007/s12035-012-8334-1.
Infectious agents and neurodegeneration.
De Chiara G, Marcocci M, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R
Mol Neurobiol. 2012; 46(3):614-38.
PMID: 22899188
PMC: 3496540.
DOI: 10.1007/s12035-012-8320-7.
Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.
Prediger R, Aguiar Jr A, Matheus F, Walz R, Antoury L, Raisman-Vozari R
Neurotox Res. 2011; 21(1):90-116.
PMID: 22002807
DOI: 10.1007/s12640-011-9281-8.
The impact of genetic research on our understanding of Parkinson's disease.
Martin I, Dawson V, Dawson T
Prog Brain Res. 2010; 183:21-41.
PMID: 20696313
PMC: 4451604.
DOI: 10.1016/S0079-6123(10)83002-X.
Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries.
Henry J, Smeyne R, Jang H, Miller B, Okun M
Parkinsonism Relat Disord. 2010; 16(9):566-71.
PMID: 20650672
PMC: 4684089.
DOI: 10.1016/j.parkreldis.2010.06.012.
Viral parkinsonism.
Jang H, Boltz D, Webster R, Smeyne R
Biochim Biophys Acta. 2008; 1792(7):714-21.
PMID: 18760350
PMC: 4642437.
DOI: 10.1016/j.bbadis.2008.08.001.
The etiology of idiopathic parkinsonism.
Uitti R
Parkinsonism Relat Disord. 1995; 1(2):65-6.
PMID: 18591003
PMC: 7129570.
DOI: 10.1016/1353-8020(95)00016-x.
Diagnosis and treatment of Parkinson disease: molecules to medicine.
Savitt J, Dawson V, Dawson T
J Clin Invest. 2006; 116(7):1744-54.
PMID: 16823471
PMC: 1483178.
DOI: 10.1172/JCI29178.
The role of early life environmental risk factors in Parkinson disease: what is the evidence?.
Logroscino G
Environ Health Perspect. 2005; 113(9):1234-8.
PMID: 16140634
PMC: 1280408.
DOI: 10.1289/ehp.7573.
